https://geneonline.news/中國生技公司kailera擴大ipo規模/2026-05-04T06:25:47.000Zweekly0.8 https://geneonline.news/川普政府胜肽迷幻藥政策決策模式引發小型生技公/2026-05-04T06:25:45.000Zweekly0.8 https://geneonline.news/禿髮數據亮眼-nektar-生技募資-3-74-億美元/2026-05-04T06:25:43.000Zweekly0.8 https://geneonline.news/賽諾菲btk抑制劑獲歐盟人用藥品委員會正面意見/2026-05-04T06:25:41.000Zweekly0.8 https://geneonline.news/inventiva高層重組備戰關鍵數據發布-2/2026-05-04T06:25:40.000Zweekly0.8 https://geneonline.news/oruka新藥乾癬二期臨床數據亮眼藥效持久性待驗證/2026-05-04T06:25:38.000Zweekly0.8 https://geneonline.news/aacr會議聚焦新藥靶點與生物製藥合作-3/2026-05-04T06:25:37.000Zweekly0.8 https://geneonline.news/aacr大會發現172個腫瘤學新靶點/2026-05-04T06:25:35.000Zweekly0.8 https://geneonline.news/intellia基因療法後期報捷-crispr商業化在望/2026-05-04T06:25:34.000Zweekly0.8 https://geneonline.news/禮來併購ajax生技-sun製藥收購organon/2026-05-04T06:25:31.000Zweekly0.8 https://geneonline.news/癌症研究重大突破-美國癌症研究協會發現172個新標/2026-05-04T06:25:29.000Zweekly0.8 https://geneonline.news/歐洲投資機構kurma募資成功聚焦早期創投/2026-05-04T06:25:27.000Zweekly0.8 https://geneonline.news/aurora獲種子輪融資開發客製化鹼基編輯技術/2026-05-04T06:25:25.000Zweekly0.8 https://geneonline.news/罕見兒科疾病優先審查憑證價格居高不下-6/2026-05-04T06:25:23.000Zweekly0.8 https://geneonline.news/teva製藥七億美元收購emalex生物製藥-2/2026-05-04T06:25:22.000Zweekly0.8 https://geneonline.news/義大利藥廠奇亞esi斥資十九億美元收購kalvista擴張罕見-2/2026-05-04T06:25:20.000Zweekly0.8 https://geneonline.news/降低體內car-t細胞免疫原性研究獲突破-2/2026-05-04T06:25:18.000Zweekly0.8 https://geneonline.news/fda預算提案：兒童藥物審查永久化與諮詢委員會改/2026-05-04T06:25:17.000Zweekly0.8 https://geneonline.news/grey-wolf-和鉑醫藥人事異動-生技產業注入新活力/2026-05-04T06:25:15.000Zweekly0.8 https://geneonline.news/禮來公司斥資數十億美元收購-kelonia-therapeutics/2026-05-04T06:25:13.000Zweekly0.8 https://geneonline.news/nektar-therapeutics禿髮研究發現il2療法後期反應現象/2026-05-04T06:25:12.000Zweekly0.8 https://geneonline.news/禮來收購car-t公司kailera肥胖療法ipo受矚目/2026-05-04T06:25:10.000Zweekly0.8 https://geneonline.news/川普卸任前迷幻藥行政命令引發爭議/2026-05-04T06:25:08.000Zweekly0.8 https://geneonline.news/生技產業併購潮起-ucb禮來搶攻癲癇癌症療法/2026-05-04T06:25:07.000Zweekly0.8 https://geneonline.news/生技併購市場現重大變革-未上市生技公司估值創新/2026-05-04T06:25:05.000Zweekly0.8 https://geneonline.news/英國生技公司開發新藥-另闢蹊徑治療類風濕性關節/2026-05-04T06:25:01.000Zweekly0.8 https://geneonline.news/多區域臨床試驗未成主流藥廠審慎評估試驗設計/2026-05-04T06:24:59.000Zweekly0.8 https://geneonline.news/額顳葉失智症生物標記現蹤-有望精準診斷治療/2026-05-04T06:24:58.000Zweekly0.8 https://geneonline.news/自體免疫疾病治療新趨勢-t細胞接合器精準控制成關/2026-05-04T06:24:56.000Zweekly0.8 https://geneonline.news/安進資深主管退休-biomarin迎來新任董事長/2026-05-04T06:24:54.000Zweekly0.8 https://geneonline.news/aacr年會聚焦腫瘤治療數據應用與技術創新-2/2026-05-04T06:24:53.000Zweekly0.8 https://geneonline.news/廣效性ras抑制劑adc有望克服癌症治療挑戰/2026-05-04T06:24:51.000Zweekly0.8 https://geneonline.news/創投挹注tortugas加速神經系統疾病藥物研發/2026-05-04T06:24:49.000Zweekly0.8 https://geneonline.news/細胞療法早期臨床試驗領先-中國生技公司成推動主/2026-05-04T06:24:47.000Zweekly0.8 https://geneonline.news/生技併購案或有價值權利成常態/2026-05-04T06:24:46.000Zweekly0.8 https://geneonline.news/生物科技產業投資熱絡-coultreon獲巨額融資/2026-05-04T06:24:44.000Zweekly0.8 https://geneonline.news/syncona轉向因果生物學-擴大基因療法外投資/2026-05-04T06:24:43.000Zweekly0.8 https://geneonline.news/前fda顧問解析藥品審查：謹慎獨立與程序的重要性/2026-05-04T06:24:41.000Zweekly0.8 https://geneonline.news/腦白質退化症藥物開發邁向精準治療-3/2026-05-04T06:24:40.000Zweekly0.8 https://geneonline.news/生技公司ipo市場表現強勁-後續募資與私募股權投資/2026-05-04T06:24:38.000Zweekly0.8 https://geneonline.news/基因體學先驅克雷格文特辭世-享耆壽-2/2026-05-04T06:24:36.000Zweekly0.8 https://geneonline.news/印度太陽製藥斥資百億美元收購organon-2/2026-05-04T06:24:35.000Zweekly0.8 https://geneonline.news/諾華藥物獲歐盟批准-慢性蕁麻疹治療現曙光/2026-05-04T06:24:33.000Zweekly0.8 https://geneonline.news/fda核准saphnelo治療全身性紅斑狼瘡-4/2026-05-04T06:24:31.000Zweekly0.8 https://geneonline.news/biomarin完成收購amicus擴大罕見疾病藥物產品線-2/2026-05-04T06:24:30.000Zweekly0.8 https://geneonline.news/rocket-pharmaceuticals出售優先審查憑證挹注基因治療研發-4/2026-05-04T06:24:28.000Zweekly0.8 https://geneonline.news/arcera攜手復星醫藥-推進神經科學創新發展/2026-05-04T06:24:27.000Zweekly0.8 https://geneonline.news/再生元財報揭露淨利下滑非通用會計準則下仍成長/2026-05-04T06:24:25.000Zweekly0.8 https://geneonline.news/ray-therapeutics基因療法獲歐盟ema優先藥物資格-4/2026-05-04T06:24:23.000Zweekly0.8 https://geneonline.news/leo-pharma收購replay強化基因療法能力-2/2026-05-04T06:24:21.000Zweekly0.8 https://geneonline.news/fda批准auvelity治療阿茲海默症躁動-13/2026-05-04T06:24:20.000Zweekly0.8 https://geneonline.news/glp1藥物法律政策高峰會探討市場挑戰與監管趨勢-2/2026-05-04T06:24:18.000Zweekly0.8 https://geneonline.news/美國fda胜肽藥物新政策解析與產業應對/2026-05-04T06:24:16.000Zweekly0.8 https://geneonline.news/美國fda發布最新指南呼籲重視過期藥品處理/2026-05-04T06:24:12.000Zweekly0.8 https://geneonline.news/美國fda趨嚴監管胜肽藥物業者面臨挑戰/2026-05-04T06:24:08.000Zweekly0.8 https://geneonline.news/美國司法部新企業執法政策衝擊fda與dea監管產業-3/2026-05-04T06:24:03.000Zweekly0.8 https://geneonline.news/美國fda重申臨床試驗報告義務/2026-05-04T06:23:58.000Zweekly0.8 https://geneonline.news/快速創新下的監管挑戰與應對/2026-05-04T06:23:52.000Zweekly0.8 https://geneonline.news/美國fda面臨挑戰：公民請願或引發訴訟戰/2026-05-04T06:23:45.000Zweekly0.8 https://geneonline.news/美國大麻產業監管現況與未來發展/2026-05-04T06:23:42.000Zweekly0.8 https://geneonline.news/fda點名七千餘家藥企未依規定申報藥品數量/2026-05-04T06:23:39.000Zweekly0.8 https://geneonline.news/樞紐中心轉型：適應性與共享策略引領患者服務新-3/2026-05-04T06:23:35.000Zweekly0.8 https://geneonline.news/藥品福利管理機構產業趨勢線上研討會2026年登場-2/2026-05-04T06:23:33.000Zweekly0.8 https://geneonline.news/藥廠應對藥品負擔挑戰-創新方案助患者用藥/2026-05-04T06:23:30.000Zweekly0.8 https://geneonline.news/美國藥局與藥品福利管理機構經濟報告揭露市場佔/2026-05-04T06:23:29.000Zweekly0.8 https://geneonline.news/醫療福利最大化機構崛起藥廠應對策略-2/2026-05-04T06:23:27.000Zweekly0.8 https://geneonline.news/美國藥局與藥品福利管理機構2026年經濟報告發布-12/2026-05-04T06:23:25.000Zweekly0.8 https://geneonline.news/藥品通路領導論壇圓滿落幕-聚焦產業發展趨勢-2/2026-05-04T06:23:24.000Zweekly0.8 https://geneonline.news/罕見疾病藥局精準照護提升患者福祉/2026-05-04T06:23:22.000Zweekly0.8 https://geneonline.news/美國三大藥品福利管理機構持續主導市場-2/2026-05-04T06:23:19.000Zweekly0.8 https://geneonline.news/三月藥品通路新聞總覽-信諾整合-默克降價-沃爾格/2026-05-04T06:23:18.000Zweekly0.8 https://geneonline.news/covermymeds-舉辦-axs26-創新圓桌會議-探討患者藥品可及性挑戰與/2026-05-04T06:23:16.000Zweekly0.8 https://geneonline.news/藥品福利管理機構面臨淨價藥品通路挑戰/2026-05-04T06:23:14.000Zweekly0.8 https://geneonline.news/藥品通路新趨勢：dci專家解析垂直整合、共付額與/2026-05-04T06:23:13.000Zweekly0.8 https://geneonline.news/藥價下調衝擊藥局與340b計畫利潤/2026-05-04T06:23:11.000Zweekly0.8 https://geneonline.news/美國聯邦貿易委員會重塑藥品福利管理模式-7/2026-05-04T06:23:10.000Zweekly0.8 https://geneonline.news/美國藥品通路淨價革命來臨-6/2026-05-04T06:23:08.000Zweekly0.8 https://geneonline.news/生命科學定價與合約美國峰會聚焦醫療保健挑戰/2026-05-04T06:23:06.000Zweekly0.8 https://geneonline.news/美國藥品通路垂直整合現況：dci報告揭示企業影響/2026-05-04T06:23:05.000Zweekly0.8 https://geneonline.news/患者支援計畫轉移需謹慎-確保服務數據完整維護品/2026-05-04T06:23:02.000Zweekly0.8 https://geneonline.news/全通路crm系統助力特殊療法提升病患服務/2026-05-04T06:22:59.000Zweekly0.8 https://geneonline.news/特殊藥房市場集中度高-pbm附屬機構佔主導地位-2/2026-05-04T06:22:55.000Zweekly0.8 https://geneonline.news/藥廠轉型直達消費者模式擴大藥品可及性-3/2026-05-04T06:22:51.000Zweekly0.8 https://geneonline.news/藥品通路四月焦點：pbm專科藥房、d部分利潤、非營/2026-05-04T06:22:43.000Zweekly0.8 https://geneonline.news/藥廠上市後毛利淨利風險增加-即時監控與干預成關/2026-05-04T06:22:36.000Zweekly0.8 https://geneonline.news/歐盟新藥聯合評估系統面臨挑戰-首份報告發布在-2/2026-05-04T06:22:27.000Zweekly0.8 https://geneonline.news/teva製藥九億美元收購emalex強化神經科學產品線-2/2026-05-04T06:22:14.000Zweekly0.8 https://geneonline.news/奇亞esi斥資十九億美元收購kalvista擴展罕見疾病產品線/2026-05-04T06:22:10.000Zweekly0.8 https://geneonline.news/抗凝血藥專利到期-藥廠面臨百億美元營收危機/2026-05-04T06:22:02.000Zweekly0.8 https://geneonline.news/leo-pharma收購replay擴大基因療法布局-3/2026-05-04T06:21:57.000Zweekly0.8 https://geneonline.news/百時美施貴寶關鍵藥物試驗結果受矚目/2026-05-04T06:21:46.000Zweekly0.8 https://geneonline.news/禮來減重療法需求激增-上調2026年營收預期-2/2026-05-04T06:21:41.000Zweekly0.8 https://geneonline.news/fda批准auvelity治療阿茲海默症躁動-12/2026-05-04T06:21:34.000Zweekly0.8 https://geneonline.news/沙烏地阿拉伯崛起為中東臨床試驗主要市場/2026-05-04T06:21:25.000Zweekly0.8 https://geneonline.news/臨床試驗技術碎片化推高成本-統一數據管理成趨勢/2026-05-04T06:21:21.000Zweekly0.8 https://geneonline.news/安邁任命nitin-lath為印度企業財務董事總經理/2026-05-04T06:21:12.000Zweekly0.8 https://geneonline.news/印度藥廠推出新注射劑對抗多重抗藥性感染-3/2026-05-04T06:21:07.000Zweekly0.8 https://geneonline.news/vision-360研討會聚焦眼科創新-產學研合作推動臨床應用/2026-05-04T06:21:01.000Zweekly0.8 https://geneonline.news/印度製藥產業盛會-epw-expo-2027-擘劃發展藍圖/2026-05-04T06:20:58.000Zweekly0.8 https://geneonline.news/印度藥廠糖尿病學名藥獲准在加拿大上市-3/2026-05-04T06:20:51.000Zweekly0.8